The promise and pitfalls of palliative care - latimes.com: If palliative care were a pill, government regulators would very likely approve it for the U.S. market. Federal healthcare insurance programs would quickly agree to pay physicians and hospitals for treating patients with the new therapy. And patients would make it a blockbuster drug in no time flat.
Yet uncertainties cloud the prospects for palliative care. Among the unanswered questions: Who will pay for these services, where will this new field's workforce come from, and what is it — cost savings or compassion — that drives this new branch of medicine?
Related: Right to Life article
'via Blog this'
No comments:
Post a Comment